Based on these findings and the neuroprotective role of mGlu3 [174–177], agonism or enhancement of mGlu3 signaling may provide pro-cognitive benefits in addition to ameliorating some of the neuroinflammatory pathology seen in schizophrenia [178, 179]. The gene discussed is GRM3; the disease is schizophrenia.